Home > Research > Publications & Outputs > Ocular surface reconstruction with a tissue-eng...
View graph of relations

Ocular surface reconstruction with a tissue-engineered nasal mucosal epithelial cell sheet for the treatment of severe ocular surface diseases

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Ocular surface reconstruction with a tissue-engineered nasal mucosal epithelial cell sheet for the treatment of severe ocular surface diseases. / Kobayashi, Masakazu; Nakamura, Takahiro; Yasuda, Makoto et al.
In: Stem Cells Translational Medicine, Vol. 4, No. 1, 01.2015, p. 99-109.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Kobayashi, M, Nakamura, T, Yasuda, M, Hata, Y, Okura, S, Iwamoto, M, Nagata, M, Fullwood, NJ, Koizumi, N, Hisa, Y & Kinoshita, S 2015, 'Ocular surface reconstruction with a tissue-engineered nasal mucosal epithelial cell sheet for the treatment of severe ocular surface diseases', Stem Cells Translational Medicine, vol. 4, no. 1, pp. 99-109. https://doi.org/10.5966/sctm.2014-0169

APA

Kobayashi, M., Nakamura, T., Yasuda, M., Hata, Y., Okura, S., Iwamoto, M., Nagata, M., Fullwood, N. J., Koizumi, N., Hisa, Y., & Kinoshita, S. (2015). Ocular surface reconstruction with a tissue-engineered nasal mucosal epithelial cell sheet for the treatment of severe ocular surface diseases. Stem Cells Translational Medicine, 4(1), 99-109. https://doi.org/10.5966/sctm.2014-0169

Vancouver

Kobayashi M, Nakamura T, Yasuda M, Hata Y, Okura S, Iwamoto M et al. Ocular surface reconstruction with a tissue-engineered nasal mucosal epithelial cell sheet for the treatment of severe ocular surface diseases. Stem Cells Translational Medicine. 2015 Jan;4(1):99-109. Epub 2014 Nov 19. doi: 10.5966/sctm.2014-0169

Author

Kobayashi, Masakazu ; Nakamura, Takahiro ; Yasuda, Makoto et al. / Ocular surface reconstruction with a tissue-engineered nasal mucosal epithelial cell sheet for the treatment of severe ocular surface diseases. In: Stem Cells Translational Medicine. 2015 ; Vol. 4, No. 1. pp. 99-109.

Bibtex

@article{bfa3ba1809214c2caa819d7276c7e359,
title = "Ocular surface reconstruction with a tissue-engineered nasal mucosal epithelial cell sheet for the treatment of severe ocular surface diseases",
abstract = "Severe ocular surface diseases (OSDs) with severe dry eye can be devastating and are currently some of the most challenging eye disorders to treat. To investigate the feasibility of using an autologous tissue-engineered cultivated nasal mucosal epithelial cell sheet (CNMES) for ocular surface reconstruction, we developed a novel technique for the culture of nasal mucosal epithelial cells expanded ex vivo from biopsy-derived human nasal mucosal tissues. After the protocol, the CNMESs had 4-5 layers of stratified, well-differentiated cells, and we successfully generated cultured epithelial sheets, including numerous goblet cells. Immunohistochemistry confirmed the presence of keratins 3, 4, and 13; mucins 1, 16, and 5AC; cell junction and basement membrane assembly proteins; and stem/progenitor cell marker p75 in the CNMESs. We then transplanted the CNMESs onto the ocular surfaces of rabbits and confirmed the survival of this tissue, including the goblet cells, up to 2 weeks. The present report describes an attempt to overcome the problems of treating severe OSDs with the most severe dry eye by treating them using tissue-engineered CNMESs to supply functional goblet cells and to stabilize and reconstruct the ocular surface. The present study is a first step toward assessing the use of tissue-engineered goblet-cell transplantation of nonocular surface origin for ocular surface reconstruction.",
keywords = "Nasal mucosa , Ocular surface, Dry eye, Goblet cell, Mucin",
author = "Masakazu Kobayashi and Takahiro Nakamura and Makoto Yasuda and Yuiko Hata and Shoki Okura and Miyu Iwamoto and Maho Nagata and Fullwood, {Nigel J.} and Noriko Koizumi and Yasuo Hisa and Shigeru Kinoshita",
year = "2015",
month = jan,
doi = "10.5966/sctm.2014-0169",
language = "English",
volume = "4",
pages = "99--109",
journal = "Stem Cells Translational Medicine",
issn = "2157-6564",
publisher = "AlphaMed Press",
number = "1",

}

RIS

TY - JOUR

T1 - Ocular surface reconstruction with a tissue-engineered nasal mucosal epithelial cell sheet for the treatment of severe ocular surface diseases

AU - Kobayashi, Masakazu

AU - Nakamura, Takahiro

AU - Yasuda, Makoto

AU - Hata, Yuiko

AU - Okura, Shoki

AU - Iwamoto, Miyu

AU - Nagata, Maho

AU - Fullwood, Nigel J.

AU - Koizumi, Noriko

AU - Hisa, Yasuo

AU - Kinoshita, Shigeru

PY - 2015/1

Y1 - 2015/1

N2 - Severe ocular surface diseases (OSDs) with severe dry eye can be devastating and are currently some of the most challenging eye disorders to treat. To investigate the feasibility of using an autologous tissue-engineered cultivated nasal mucosal epithelial cell sheet (CNMES) for ocular surface reconstruction, we developed a novel technique for the culture of nasal mucosal epithelial cells expanded ex vivo from biopsy-derived human nasal mucosal tissues. After the protocol, the CNMESs had 4-5 layers of stratified, well-differentiated cells, and we successfully generated cultured epithelial sheets, including numerous goblet cells. Immunohistochemistry confirmed the presence of keratins 3, 4, and 13; mucins 1, 16, and 5AC; cell junction and basement membrane assembly proteins; and stem/progenitor cell marker p75 in the CNMESs. We then transplanted the CNMESs onto the ocular surfaces of rabbits and confirmed the survival of this tissue, including the goblet cells, up to 2 weeks. The present report describes an attempt to overcome the problems of treating severe OSDs with the most severe dry eye by treating them using tissue-engineered CNMESs to supply functional goblet cells and to stabilize and reconstruct the ocular surface. The present study is a first step toward assessing the use of tissue-engineered goblet-cell transplantation of nonocular surface origin for ocular surface reconstruction.

AB - Severe ocular surface diseases (OSDs) with severe dry eye can be devastating and are currently some of the most challenging eye disorders to treat. To investigate the feasibility of using an autologous tissue-engineered cultivated nasal mucosal epithelial cell sheet (CNMES) for ocular surface reconstruction, we developed a novel technique for the culture of nasal mucosal epithelial cells expanded ex vivo from biopsy-derived human nasal mucosal tissues. After the protocol, the CNMESs had 4-5 layers of stratified, well-differentiated cells, and we successfully generated cultured epithelial sheets, including numerous goblet cells. Immunohistochemistry confirmed the presence of keratins 3, 4, and 13; mucins 1, 16, and 5AC; cell junction and basement membrane assembly proteins; and stem/progenitor cell marker p75 in the CNMESs. We then transplanted the CNMESs onto the ocular surfaces of rabbits and confirmed the survival of this tissue, including the goblet cells, up to 2 weeks. The present report describes an attempt to overcome the problems of treating severe OSDs with the most severe dry eye by treating them using tissue-engineered CNMESs to supply functional goblet cells and to stabilize and reconstruct the ocular surface. The present study is a first step toward assessing the use of tissue-engineered goblet-cell transplantation of nonocular surface origin for ocular surface reconstruction.

KW - Nasal mucosa

KW - Ocular surface

KW - Dry eye

KW - Goblet cell

KW - Mucin

U2 - 10.5966/sctm.2014-0169

DO - 10.5966/sctm.2014-0169

M3 - Journal article

C2 - 25411478

VL - 4

SP - 99

EP - 109

JO - Stem Cells Translational Medicine

JF - Stem Cells Translational Medicine

SN - 2157-6564

IS - 1

ER -